Equities

Owens & Minor Inc

Owens & Minor Inc

Actions
Health CareHealth Care Equipment & Services
  • Price (USD)16.62
  • Today's Change-0.39 / -2.29%
  • Shares traded1.96m
  • 1 Year change477.08%
  • Beta0.6233
Data delayed at least 15 minutes, as of Aug 04 2020 21:10 BST.
More ▼

Profile data is unavailable for this security.

About the company

Owens & Minor, Inc. is a healthcare solutions company with integrated technologies, products and services. The Company operates through two segments: Global Solutions and Global Products. Global Solutions segment includes its United States distribution, outsourced logistics and value-added services business. Global Products manufactures and sources medical surgical products through its production and kitting operations. Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes products purchased from manufacturers and its own proprietary products. Global Products segment provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. Its manufacturing facilities are located in the United States, Thailand, Honduras, Mexico and Ireland.

  • Revenue in USD (TTM)8.87bn
  • Net income in USD-22.60m
  • Incorporated1993
  • Employees6.40k
  • Location
    Owens & Minor Inc9120 LOCKWOOD BLVDMECHANICSVILLE 23116United StatesUSA
  • Phone+1 (804) 723-7000
  • Fax+1 (804) 723-7100
  • Websitehttp://www.owens-minor.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Fulgent Genetics Inc34.91m-459.00k644.21m139.00--7.91265.2218.45-0.0131-0.01311.753.750.4816--6.30251,158.300.3973-7.550.4236-7.9856.4755.060.825-16.57----0.00--52.3591.0592.67--10.09--
BioLife Solutions Inc33.76m16.28m670.29m151.0030.766.5628.5419.850.68240.68241.483.200.4721.576.07223,596.0028.27-31.9035.20-35.4365.4165.2059.90-57.980.61364.220.00--38.6434.6293.46--31.63--
Inogen Inc360.23m14.06m675.54m1.02k48.771.9422.851.880.62830.628316.3115.750.85035.858.79353,166.703.3210.113.7611.5046.0348.473.9010.034.75--0.000.001.0726.32-59.5931.7814.11--
Tactile Systems Technology Inc185.47m-8.44m689.55m629.00--6.67--3.72-0.4429-0.44299.535.331.414.826.71294,864.90-6.417.27-7.538.7550.6650.20-4.554.903.89--0.000.0031.8231.7565.65159.6376.16--
Cryolife Inc257.78m-11.25m757.16m1.20k--2.5595.792.94-0.300-0.29596.907.840.39951.595.16214,815.00-1.760.816-1.880.885166.6665.80-4.391.584.590.50700.498920.815.0913.81150.90-26.348.70--
Co-Diagnostics Inc1.76m-5.89m779.23m27.00--40.65--442.72-0.3311-0.33110.09540.69820.13231.693.2176,526.09-44.30-256.57-47.01-1,630.7466.2755.19-334.77-8,585.3015.86-33.430.00--438.64--1.21--56.95--
Lantheus Holdings Inc331.84m11.63m845.86m508.0041.931.6430.842.550.30190.30198.117.720.52265.157.18653,220.501.837.432.048.6747.4048.543.517.561.913.580.30580.001.152.86-21.84--22.08--
Orthopediatrics Corp74.25m-14.61m893.80m94.00--5.56--12.04-0.9557-1.034.918.250.51890.50186.08789,914.90-10.21-13.18-11.17-14.8375.6673.66-19.68-19.705.14-2.800.132--26.0525.09-5.49--29.50--
Heska Corp123.80m-7.57m939.10m386.00--2.90--7.59-1.01-1.0116.5334.510.4822.437.49320,735.80-2.885.38-3.166.7044.7143.55-5.976.169.89-0.07510.1506---3.756.43-125.04---14.88--
Owens & Minor, Inc.8.87bn-22.60m1.05bn6.40k--2.5111.730.118-0.3751-0.9835147.136.622.346.7511.741,386,288.00-0.5949-1.05-0.9745-1.7111.7112.17-0.2547-0.35170.91051.040.781---2.20-0.490594.28---5.91-60.19
Meridian Bioscience, Inc.204.00m21.37m1.09bn660.0051.155.3333.055.350.49770.49774.754.780.7122.075.57309,095.507.4611.438.3612.5158.4861.8510.4713.492.5217.870.192790.63-5.881.2610.48-6.84-11.52-20.56
Inmode Ltd166.25m57.45m1.17bn251.0021.746.0220.277.051.511.514.295.471.062.3126.57662,350.6036.53--44.17--86.68--34.58--7.27--0.00--56.11--173.32------
Atrion Corporation157.05m36.21m1.19bn616.0033.225.0625.107.5619.4419.4584.34127.720.62642.307.13254,944.8014.4416.1015.1716.9345.7547.3323.0521.616.70--0.0026.061.721.957.275.7310.0415.84
Cardiovascular Systems Inc262.23m-10.60m1.22bn731.00--7.59--4.64-0.3114-0.31147.734.061.222.407.97358,731.90-4.92-9.79-6.22-12.1980.1480.43-4.04-8.662.80--0.1272--14.2712.67-114.89---23.33--
Vapotherm Inc54.92m-51.94m1.32bn279.00--26.67--23.98-2.67-2.672.801.980.54892.755.90196,845.90-51.91---62.44--46.16---94.57--3.56-10.810.5284--13.51---20.23------
GenMark Diagnostics, Inc105.23m-42.28m1.33bn437.00--90.09--12.65-0.7252-0.72521.800.2121.016.876.03240,800.90-40.60-53.95-51.65-69.2436.9640.59-40.18-84.172.78-5.730.8427--24.4023.546.24---19.20--
Data as of Aug 04 2020. Currency figures normalised to Owens & Minor Inc's reporting currency: US Dollar USD

Institutional shareholders

53.31%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Mar 20209.02m14.32%
The Vanguard Group, Inc.as of 31 Mar 20205.04m8.01%
Dimensional Fund Advisors LPas of 31 Mar 20204.95m7.86%
Renaissance Technologies LLCas of 31 Mar 20203.03m4.81%
SSgA Funds Management, Inc.as of 31 Mar 20202.65m4.21%
JPMorgan Investment Management, Inc.as of 31 Mar 20202.24m3.56%
Royce & Associates LPas of 31 Mar 20202.05m3.26%
LSV Asset Managementas of 31 Mar 20201.81m2.88%
Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 20201.57m2.48%
Invesco Capital Management LLCas of 31 Mar 20201.21m1.93%
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.